Indexed in Journament

Annals of hematology

ISSN 1432-0584· EN

Certificate of Indexing
Login or register to claim ownership or editorship of this journal.
38.6 / 100
Journament Score
Poor
Ranked #9,796 of 29,341 scored journals (33,995 indexed)
85 Articles
Scores higher than 66.6% of scored journals
050100
The Journament Score is computed from platform statistics — reader engagement, accessibility, publication timeliness, keyword breadth, community impact and content distribution — into a single 0–100 figure, recalculated as new articles and metadata are indexed. Dimensions that cannot be measured for this journal are excluded rather than estimated. It is independent of the paid AI Quality Analysis, which never affects this score or the ranking. Full methodology →

About This Journal

Short Name Ann Hematol
Abbreviated Name ann hematol
ISSN 1432-0584

Quality Profile

7 of 12 dimensions measured
This journal Average of scored journals
Platform statistics — the free Journament Score AI Quality Analysis — separate paid product, ranks nothing

5 of the 12 dimensions could not be measured for this journal. They are left as gaps in the shape rather than plotted as zero.

Show the numbers
Dimension This journal Corpus average
Engagement 30.7 30.1
Accessibility 15.0 17.9
Timeliness 50.0 19.2
Diversity 30.0 28.8
Innovation 40.0 31.2
Community Impact 34.5 13.4
Content Distribution 70.6 88.4
Content Quality — 55.5
Ethics & Transparency — 40.2
Editorial Standards — 33.4
Publication Regularity — 53.2
Geographic Reach — 30.8

Publications Per Year

Articles (85)

2020
Phenotypic characterization of macrophages in the BMB sample of human acute leukemia.
Song, Jian-Xin;Wen, Yan;Li, Rui-Wei;Dong, Ting;Tang, Yi-Fei;Zhang, Juan-Juan;Sa, Ya-Lian;
442 views DOI Abstract
2020
Mosaicism in Fanconi anemia: concise review and evaluation of published cases with focus on clinical course of blood count normalization.
Nicoletti, Eileen;Rao, Gayatri;Bueren, Juan A;Río, Paula;Navarro, Susana;Surrallés, Jordi;Choi, Grace;Schwartz, Jonathan D;
, pp. 0-0
375 views DOI Abstract
2017
Evaluation of cardiovascular ischemic event rates in dasatinib-treated patients using standardized incidence ratios.
Saglio, Giuseppe;le Coutre, Philipp;Cortes, Jorge;Mayer, Jiří;Rowlings, Philip;Mahon, François-Xavier;Kroog, Glenn;Gooden, Kyna;Subar, Milayna;Shah, Neil P;
Vol. 96 , No. 8 , pp. 1303-1313
375 views DOI Abstract
1970
DNA fragmentation as a consequence of cell cycle traverse in doxorubicin- and idarubicin-treated human lymphoma cells
P. J. Smith;C. Rackstraw;F. Cotter;P. J. Smith;C. Rackstraw;F. Cotter;
Vol. 69 , No. 1 , pp. S7-S11
375 views DOI Abstract
2019
Use of eltrombopag in aplastic anemia in Europe.
Ecsedi, Matyas;Lengline, Étienne;Knol-Bout, Cora;Bosman, Paul;Eikema, Dirk-Jan;Afanasyev, Boris;Maschan, Alexei;Dreger, Peter;Halkes, Constantijn J M;Drexler, Beatrice;Cortelezzi, Agostino;Drénou, Bernard;Patriarca, Andrea;Bruno, Benedetto;Onofrillo, Daniela;Lanino, Edoardo;Pulanic, Drazen;Serventi-Seiwerth, Ranka;Garnier, Alice;Ljungman, Per;Bonifazi, Francesca;Giammarco, Sabrina;Tournilhac, Olivier;Pioltelli, Pietro;Rovó, Alicia;Risitano, Antonio M;de Latour, Régis Peffault;Dufour, Carlo;Passweg, Jakob;, ;
Vol. 98 , No. 6 , pp. 1341-1350
365 views DOI Abstract
2005
Is splenectomy a contraindication for patients with myelodysplastic syndromes complicated by splenomegaly?
Ryo Uchida;Sonoko Nakano;Kyoko Namura;Noriko Yamada;Shin-ichi Fuchida;Akira Okano;Masashi Okamoto;Naoya Ochiai;Chihiro Shimazaki;Ryo Uchida;Sonoko Nakano;Kyoko Namura;Noriko Yamada;Shin-ichi Fuchida;Akira Okano;Masashi Okamoto;Naoya Ochiai;Chihiro Shimazaki;
Vol. 85 , No. 3 , pp. 198-199
358 views DOI
2006
Erythropoietin plus granulocyte colony-stimulating factor is better than erythropoietin alone to treat anemia in low-risk myelodysplastic syndromes: results from a randomized single-centre study
Enrico Balleari;Edoardo Rossi;Marino Clavio;Angela Congiu;Marco Gobbi;Marco Grosso;Vincenzo Secondo;Mauro Spriano;Silvana Timitilli;Riccardo Ghio;Enrico Balleari;Edoardo Rossi;Marino Clavio;Angela Congiu;Marco Gobbi;Marco Grosso;Vincenzo Secondo;Mauro Spriano;Silvana Timitilli;Riccardo Ghio;
Vol. 85 , No. 3 , pp. 174-180
351 views DOI Abstract
2012
(Bortezomib plus lenalidomide/thalidomide)- vs (bortezomib or lenalidomide/thalidomide)-containing regimens as induction therapy in newly diagnosed multiple myeloma: a meta-analysis of randomized controlled trials
Anyou Wang;Qiaohong Duan;Xin Liu;Kaiyang Ding;Yongsheng Han;Weibo Zhu;Xiaoyan Cai;Jingsheng Wu;Zimin Sun;Anyou Wang;Qiaohong Duan;Xin Liu;Kaiyang Ding;Yongsheng Han;Weibo Zhu;Xiaoyan Cai;Jingsheng Wu;Zimin Sun;
Vol. 91 , No. 11 , pp. 1779-1784
343 views DOI Abstract
2020
The classic prognostic factors in advanced Hodgkin's lymphoma patients are losing their meaning at the time of Pet-guided treatments
Bari A;Marcheselli R;Sacchi S;Re A;Pagani C;Tucci A;Botto B;Vitolo U;Molinari AL;Puccini B;Pulsoni A;Santoro A;Tani M;Nassi L;Meli E;Pavone V;Bonfichi M;Evangelista A;Gioia D;Levis A;Zinzani P; ;;
Vol. 99 , No. 2 , pp. -
342 views Abstract
1970
FAB classification of myelodysplastic syndromes: merits and controversies
G. E. G. Verhoef;S. Pittaluga;C. De Wolf-Peeters;M. A. Boogaerts;G. E. G. Verhoef;S. Pittaluga;C. De Wolf-Peeters;M. A. Boogaerts;
Vol. 71 , No. 1 , pp. 3-11
335 views DOI Abstract
2025
Targeted antineoplastic therapy in critically ill cancer patients: a multicenter analysis of the iCHOP registry.
Storck, Anthea; Beutel, Gernot; Kochanek, Matthias; Schellongowski, Peter; Staudinger, Thomas; Buchtele, Nina; Cserna, Julia; Brueder, Nicole; Lueck, Catherina; Liebregts, Tobias; Tzalavras, Asterios; Hammersen, Jakob; Kroschinsky, Frank; Forkert, Randolf; Kiehl, Michael G; von Bergwelt-Baildon, Michael; Grans-Sibel, Judit; Bach, Franziska; Borrega, Jorge Garcia; Naendrup, Jan-Hendrik; Shimabukuro-Vornhagen, Alexander; Eichenauer, Dennis A; Böll, Boris
43 views DOI Abstract
2020
Nivolumab for relapsed or refractory Hodgkin lymphoma: real-life experience.
Bekoz, Huseyin;Ozbalak, Murat;Karadurmus, Nuri;Paydas, Semra;Turker, Alev;Toptas, Tayfur;Tuglular, Tülin Firatli;Altuntas, Fevzi;Cakar, Merih Kizil;Sonmez, Mehmet;Gulbas, Zafer;Demir, Nazlı;Kaynar, Leylagul;Yildirim, Rahsan;Karadogan, Ihsan;Arat, Mutlu;Kapucu, Irem;Aslan, Nevin Alayvaz;Ozkocaman, Vildan;Turgut, Mehmet;Yuksel, Meltem Kurt;Ozcan, Muhit;Hacioglu, Sibel Kabukcu;Barista, Ibrahim;Demirkaya, Metin;Saydam, Guray;Toprak, Selami K;Yilmaz, Mehmet;Demirkol, Onur;Ferhanoglu, Burhan;
Vol. 99 , No. 11 , pp. 2565-2576
253 views DOI Abstract
2020
The classic prognostic factors in advanced Hodgkin's lymphoma patients are losing their meaning at the time of Pet-guided treatments
Bari A;Marcheselli R;Sacchi S;Re A;Pagani C;Tucci A;Botto B;Vitolo U;Molinari AL;Puccini B;Pulsoni A;Santoro A;Tani M;Nassi L;Meli E;Pavone V;Bonfichi M;Evangelista A;Gioia D;Levis A;Zinzani P; ;;
Vol. 99 , No. 2 , pp. -
342 views Abstract
2020
Mosaicism in Fanconi anemia: concise review and evaluation of published cases with focus on clinical course of blood count normalization.
Nicoletti, Eileen;Rao, Gayatri;Bueren, Juan A;Río, Paula;Navarro, Susana;Surrallés, Jordi;Choi, Grace;Schwartz, Jonathan D;
, pp. 0-0
375 views DOI Abstract
2020
Burden of illness among patients with severe aplastic anemia who have had insufficient response to immunosuppressive therapy: a multicenter retrospective chart review study.
Peffault de Latour, Régis;Huynh, Lynn;Ivanova, Jasmina I;Totev, Todor;Bilginsoy, Mehmet;Antin, Joseph;Roy, Anuja;Duh, Mei Sheng;
330 views DOI Abstract
2020
Phenotypic characterization of macrophages in the BMB sample of human acute leukemia.
Song, Jian-Xin;Wen, Yan;Li, Rui-Wei;Dong, Ting;Tang, Yi-Fei;Zhang, Juan-Juan;Sa, Ya-Lian;
442 views DOI Abstract
2020
Chronic thromboembolic pulmonary hypertension from synchronous idiopathic upper extremity deep vein thrombosis and pulmonary embolism.
Yuen, Hiu Lam Agnes;Williams, Trevor J;McGiffin, David;Chunilal, Sanjeev;
288 views DOI
2019
The abnormal function of CD39<sup>+</sup> regulatory T cells could be corrected by high-dose dexamethasone in patients with primary immune thrombocytopenia
Lu, Y.
Vol. 98 , pp. 1845-1854
245 views DOI
2019
Efficacy and safety of ruxolitinib and hydroxyurea combination in patients with hyperproliferative myelofibrosis.
Breccia, Massimo;Luciano, Luigiana;Pugliese, Novella;Rossi, Elena;Tiribelli, Mario;Scalzulli, Emilia;Bonifacio, Massimiliano;Martino, Bruno;Latagliata, Roberto;Benevolo, Giulia;Caocci, Giovanni;Binotto, Gianni;Martinelli, Vincenzo;Cavo, Michele;Pane, Fabrizio;De Stefano, Valerio;Foà, Robin;Palandri, Francesca;
Vol. 98 , No. 8 , pp. 1933-1936
316 views DOI Abstract
2019
Use of eltrombopag in aplastic anemia in Europe.
Ecsedi, Matyas;Lengline, Étienne;Knol-Bout, Cora;Bosman, Paul;Eikema, Dirk-Jan;Afanasyev, Boris;Maschan, Alexei;Dreger, Peter;Halkes, Constantijn J M;Drexler, Beatrice;Cortelezzi, Agostino;Drénou, Bernard;Patriarca, Andrea;Bruno, Benedetto;Onofrillo, Daniela;Lanino, Edoardo;Pulanic, Drazen;Serventi-Seiwerth, Ranka;Garnier, Alice;Ljungman, Per;Bonifazi, Francesca;Giammarco, Sabrina;Tournilhac, Olivier;Pioltelli, Pietro;Rovó, Alicia;Risitano, Antonio M;de Latour, Régis Peffault;Dufour, Carlo;Passweg, Jakob;, ;
Vol. 98 , No. 6 , pp. 1341-1350
365 views DOI Abstract
Journament Score
38.6/100 · Poor
Ranked #9,796 of 29,341 scored
(33,995 journals indexed)
Platform Statistics
AI Quality Analysis
Separate paid analysis — does not affect ranking.
Journament

Overall Quality Score

38.6/100

Tier: Poor

The Journament Overall Quality Score is a comprehensive metric that evaluates academic journals across multiple dimensions including engagement, accessibility, diversity, innovation, and community impact.

This score helps researchers, institutions, and publishers understand the holistic quality and impact of a journal beyond traditional metrics.

Engagement Score

30.7/100

Measures user interactions, views, citations, and community involvement with this journal's content.

Higher engagement scores indicate that the journal's content is actively being read, cited, and discussed within the academic community.

Accessibility Score

15.0/100

Evaluates how easily researchers can access journal content, including open access availability, ISSN registration, and indexing.

This metric considers factors such as paywalls, open access policies, and availability across different academic databases and search engines.

Diversity Score

30.0/100

Assesses geographic and institutional diversity of authors, editorial board composition, and topic breadth.

A diverse journal publishes work from various geographic regions, institutions, and covers a broad range of topics within its field.

Innovation Score

40.0/100

Evaluates research novelty, interdisciplinary work, and emerging topics based on AI analysis of article abstracts.

This score reflects how much the journal publishes cutting-edge research, explores new methodologies, and bridges different academic disciplines.

Community Impact Score

34.5/100

Measures scholarly contribution and real-world applications of published research.

This metric evaluates how the journal's research translates into practical applications, policy changes, and benefits to society beyond academia.

Timeliness Score

50.0/100

Evaluates recent publication activity, publication frequency, and currency of research topics.

Higher scores indicate consistent publishing schedules and timely coverage of current research trends.

Content Distribution

70.6/100

Measures how evenly reader attention spreads across the journal's articles, using the Gini coefficient of article clicks.

Higher scores mean readership is distributed across many articles rather than concentrated on one or two.

Ethics & Transparency Score

Not yet measured

Research Integrity (10% weight)

Assesses COPE standards compliance, ethical considerations in research, transparency in methodologies, and reproducibility practices.

This metric ensures the journal maintains high ethical standards and promotes transparent, trustworthy research.

Content Quality Score

Not yet measured

Academic Rigor (20% weight) + Methodology Quality (12%)

Evaluates research methodology soundness, statistical rigor, theoretical framework strength, appropriateness of research methods, data quality, and clarity & readability.

This comprehensive metric ensures published research meets the highest academic standards.

Editorial Diversity Score

Not yet measured

Author Diversity + Interdisciplinary Value (8%)

Measures geographic diversity of authors, institutional variety, editorial board composition, and cross-disciplinary connections.

Diverse editorial teams bring varied perspectives and reduce bias in academic publishing.

Publication Regularity Score

Not yet measured

Assesses consistency of publication schedule, frequency stability, and predictable output patterns.

Regular publication schedules indicate reliable journal operations and consistent workflow management.

Geographic Reach Score

Not yet measured

Evaluates international author representation, global readership distribution, and cross-border research collaboration.

Wide geographic reach indicates global impact and international recognition of the journal's research.